{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:04:52Z","timestamp":1774569892651,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"published-print":{"date-parts":[[2012,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Daptomycin is licensed in adults for the management of <jats:italic>Staphylococcus aureus<\/jats:italic> methicillin-resistant infections, including bone and skin complicated infections. We describe for the first time its use in a renal transplant recipient for Fabry-Anderson Disease with right heel osteomyelitis. The patient was unresponsive to first-line Teicoplanin and second-line Tigecycline, whereas he was successfully treated with third-line Daptomycin monotherapy at 4 mg\/Kg\/qd for 4 weeks. Local debridement was performed in advance of each line of treatment.<\/jats:p>","DOI":"10.1186\/1476-0711-11-6","type":"journal-article","created":{"date-parts":[[2012,3,11]],"date-time":"2012-03-11T19:14:00Z","timestamp":1331493240000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Successful salvage therapy with Daptomycin for osteomyelitis caused by methicillin-resistant Staphylococcus aureus in a renal transplant recipient with Fabry-Anderson disease"],"prefix":"10.1186","volume":"11","author":[{"given":"Ennio","family":"Polilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Ursini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Mazzotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Sozio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Savini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Domenico","family":"D'Antonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelino","family":"Barbato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusta","family":"Consorte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Parruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,3,11]]},"reference":[{"key":"247_CR1","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1086\/518452","volume":"44","author":"S Deresinski","year":"2007","unstructured":"Deresinski S: Counterpoint: vancomycin and staphylococcus aureus--an antibiotic enters obsolescence. Clin Infect Dis. 2007, 44: 1543-1548. 10.1086\/518452","journal-title":"Clin Infect Dis"},{"key":"247_CR2","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s11999-010-1271-2","volume":"468","author":"DC Allison","year":"2010","unstructured":"Allison DC, Holtom PD, Patzakis MJ, Zalavras CG: Microbiology of bone and joint infections in injecting drug abusers. Clin Orthop Relat Res. 2010, 468: 2107-2112. 10.1007\/s11999-010-1271-2","journal-title":"Clin Orthop Relat Res"},{"key":"247_CR3","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1007\/s00776-007-1207-1","volume":"13","author":"I Brook","year":"2008","unstructured":"Brook I: Microbiology and management of joint and bone infections due to anaerobic bacteria. J Orthop Sci. 2008, 13: 160-169. 10.1007\/s00776-007-1207-1","journal-title":"J Orthop Sci"},{"key":"247_CR4","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1086\/520743","volume":"28","author":"BA Lipsky","year":"2007","unstructured":"Lipsky BA, Weigelt JA, Gupta V, Killian A, Peng MM: Skin, soft tissue, bone, and joint infections in hospitalized patients: epidemiology and microbiological, clinical, and economic outcomes. Infect Control Hosp Epidemiol. 2007, 28: 1290-1298. 10.1086\/520743","journal-title":"Infect Control Hosp Epidemiol"},{"key":"247_CR5","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2165\/00003495-199754020-00004","volume":"54","author":"JT Mader","year":"1997","unstructured":"Mader JT, Mohan D, Calhoun J: A practical guide to the diagnosis and management of bone and joint infections. Drugs. 1997, 54: 253-264. 10.2165\/00003495-199754020-00004","journal-title":"Drugs"},{"key":"247_CR6","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1086\/527392","volume":"46","author":"DM Sievert","year":"2008","unstructured":"Sievert DM, Rudrik JT, Patel JB, McDonald LC, Wilkins MJ, Hageman JC: Vancomycin-resistant Staphylococcus aureus in the United States, 2002-2006. Clin Infect Dis. 2008, 46: 668-674. 10.1086\/527392","journal-title":"Clin Infect Dis"},{"key":"247_CR7","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0958-1669(03)00036-3","volume":"14","author":"S Molin","year":"2003","unstructured":"Molin S, Tolker-Nielsen T: Gene transfer occurs with enhanced efficiency in biofilms and induces enhanced stabilisation of the biofilm structure. Curr Opin Biotechnol. 2003, 14: 255-261. 10.1016\/S0958-1669(03)00036-3","journal-title":"Curr Opin Biotechnol"},{"key":"247_CR8","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s00776-005-0968-7","volume":"11","author":"S Nishimura","year":"2006","unstructured":"Nishimura S, Tsurumoto T, Yonekura A, Adachi K, Shindo H: Antimicrobial susceptibility of Staphylococcus aureus and Staphylococcus epidermidis biofilms isolated from infected total hip arthroplasty cases. J Orthop Sci. 2006, 11: 46-50. 10.1007\/s00776-005-0968-7","journal-title":"J Orthop Sci"},{"key":"247_CR9","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.surg.2009.03.037","volume":"146","author":"RS Chamberlain","year":"2009","unstructured":"Chamberlain RS, Culshaw DL, Donovan BJ, Lamp KC: Daptomycin for the treatment of surgical site infections. Surgery. 2009, 146: 316-324. 10.1016\/j.surg.2009.03.037","journal-title":"Surgery"},{"key":"247_CR10","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00402-008-0772-x","volume":"129","author":"DA Rice","year":"2009","unstructured":"Rice DA, Mendez-Vigo L: Daptomycin in bone and joint infections: a review of the literature. Arch Orthop Trauma Surg. 2009, 129: 1495-1504. 10.1007\/s00402-008-0772-x","journal-title":"Arch Orthop Trauma Surg"},{"key":"247_CR11","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/jac\/dkq109","volume":"65","author":"F Traunmuller","year":"2010","unstructured":"Traunmuller F, Schintler MV, Metzler J, Spendel S, Mauric O, Popovic M, Konz KH, Scharnagl E, Joukhadar C: Soft tissue and bone penetration abilities of daptomycin in diabetic patients with bacterial foot infections. J Antimicrob Chemother. 2010, 65: 1252-1257. 10.1093\/jac\/dkq109","journal-title":"J Antimicrob Chemother"},{"key":"247_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0272-6386(12)70118-X","volume":"19","author":"BA Julian","year":"1992","unstructured":"Julian BA, Quarles LD, Niemann KM: Musculoskeletal complications after renal transplantation: pathogenesis and treatment. Am J Kidney Dis. 1992, 19: 99-120.","journal-title":"Am J Kidney Dis"},{"key":"247_CR13","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1007\/s004670000359","volume":"14","author":"SM Sprague","year":"2000","unstructured":"Sprague SM: Mechanism of transplantation-associated bone loss. Pediatr Nephrol. 2000, 14: 650-653. 10.1007\/s004670000359","journal-title":"Pediatr Nephrol"},{"key":"247_CR14","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1302\/0301-620X.74B6.1447256","volume":"74","author":"EH Wang","year":"1992","unstructured":"Wang EH, Simpson S, Bennet GC: Osteomyelitis of the calcaneum. J Bone Joint Surg Br. 1992, 74: 906-909.","journal-title":"J Bone Joint Surg Br"},{"key":"247_CR15","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1097\/GIM.0b013e31815cb197","volume":"9","author":"H Mersebach","year":"2007","unstructured":"Mersebach H, Johansson JO, Rasmussen AK, Bengtsson BA, Rosenberg K, Hasholt L, Sorensen SA, Sorensen SS, Feldt-Rasmussen U: Osteopenia: a common aspect of Fabry disease. Predictors of bone mineral density. Genet Med. 2007, 9: 812-818. 10.1097\/GIM.0b013e31815cb197","journal-title":"Genet Med"},{"key":"247_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","volume":"1","author":"K Hiramatsu","year":"2001","unstructured":"Hiramatsu K: Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. Lancet Infect Dis. 2001, 1: 147-155. 10.1016\/S1473-3099(01)00091-3","journal-title":"Lancet Infect Dis"},{"key":"247_CR17","doi-asserted-by":"publisher","first-page":"793","DOI":"10.2165\/0003088-200847120-00004","volume":"47","author":"S Garazzino","year":"2008","unstructured":"Garazzino S, Aprato A, Baietto L, D'Avolio A, Maiello A, De Rosa FG, Aloj D, Siccardi M, Biasibetti A, Masse A, Di Perri G: Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia. Clin Pharmacokinet. 2008, 47: 793-805. 10.2165\/0003088-200847120-00004","journal-title":"Clin Pharmacokinet"},{"key":"247_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/infdis\/147.2.352","volume":"147","author":"CW Norden","year":"1983","unstructured":"Norden CW, Shaffer M: Treatment of experimental chronic osteomyelitis due to staphylococcus aureus with vancomycin and rifampin. J Infect Dis. 1983, 147: 352-357. 10.1093\/infdis\/147.2.352","journal-title":"J Infect Dis"},{"key":"247_CR19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1128\/AAC.01602-07","volume":"52","author":"TP Lodise","year":"2008","unstructured":"Lodise TP, Lomaestro B, Graves J, Drusano GL: Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity. Antimicrob Agents Chemother. 2008, 52: 1330-1336. 10.1128\/AAC.01602-07","journal-title":"Antimicrob Agents Chemother"},{"key":"247_CR20","doi-asserted-by":"publisher","first-page":"439","DOI":"10.2165\/11319960-000000000-00000","volume":"49","author":"A Di Paolo","year":"2010","unstructured":"Di Paolo A, Malacarne P, Guidotti E, Danesi R, Del Tacca M: Pharmacological issues of linezolid: an updated critical review. Clin Pharmacokinet. 2010, 49: 439-447. 10.2165\/11319960-000000000-00000","journal-title":"Clin Pharmacokinet"},{"key":"247_CR21","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1128\/AAC.01011-09","volume":"54","author":"C Garcia-de-la-Maria","year":"2010","unstructured":"Garcia-de-la-Maria C, Marco F, Armero Y, Soy D, Moreno A, del Rio A, Almela M, Cervera C, Ninot S, Falces C, Mestres CA, Gatell JM, Jim\u00e9nez de Anta MT, Mir\u00f3 JM, Hospital Cl\u00ednic Experimental Endocarditis Study Group: Daptomycin is effective for treatment of experimental endocarditis due to methicillinresistant and glycopeptide-intermediate Staphylococcus epidermidis. Antimicrob Agents Chemother. 2010, 54: 2781-2786. 10.1128\/AAC.01011-09","journal-title":"Antimicrob Agents Chemother"},{"key":"247_CR22","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.ijantimicag.2010.03.015","volume":"36","author":"AM Chaftari","year":"2010","unstructured":"Chaftari AM, Hachem R, Mulanovich V, Chemaly RF, Adachi J, Jacobson K, Jiang Y, Raad I: Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients. Int J Antimicrob Agents. 2010, 36: 182-186. 10.1016\/j.ijantimicag.2010.03.015","journal-title":"Int J Antimicrob Agents"},{"key":"247_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijantimicag.2010.03.016","volume":"36","author":"HS Sader","year":"2010","unstructured":"Sader HS, Farrell DJ, Jones RN: Antimicrobial susceptibility of Gram-positive cocci isolated from skin and skin-structure infections in European medical centres. Int J Antimicrob Agents. 2010, 36: 28-32. 10.1016\/j.ijantimicag.2010.03.016","journal-title":"Int J Antimicrob Agents"},{"key":"247_CR24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1586\/eri.09.121","volume":"8","author":"O Burkhardt","year":"2010","unstructured":"Burkhardt O, Kielstein JT: A simplified three-times weekly daptomycin dosing regimen for chronic hemodialysis patients. Expert Rev Anti Infect Ther. 2010, 8: 11-14. 10.1586\/eri.09.121","journal-title":"Expert Rev Anti Infect Ther"},{"key":"247_CR25","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1093\/ndt\/gfp704","volume":"25","author":"JT Kielstein","year":"2010","unstructured":"Kielstein JT, Eugbers C, Bode-Boeger SM, Martens-Lobenhoffer J, Haller H, Joukhadar C, Traunm\u00fcller F, Knitsch W, Hafer C, Burkhardt O: Dosing of daptomycin in intensive care unit patients with acute kidney injury undergoing extended dialysis-a pharmacokinetic study. Nephrol Dial Transplant. 2010, 25: 1537-1541. 10.1093\/ndt\/gfp704","journal-title":"Nephrol Dial Transplant"},{"key":"247_CR26","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1016\/j.amjmed.2007.07.010","volume":"120","author":"KC Lamp","year":"2007","unstructured":"Lamp KC, Friedrich LV, Mendez-Vigo L, Russo R: Clinical experience with daptomycin for the treatment of patients with osteomyelitis. Am J Med. 2007, 120: S13-S20.","journal-title":"Am J Med"},{"key":"247_CR27","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ijantimicag.2010.07.011","volume":"36","author":"M Bassetti","year":"2010","unstructured":"Bassetti M, Nicco E, Ginocchio F, Ansaldi F, de Florentiis D, Viscoli C: High-dose daptomycin in documented Staphylococcus aureus infections. Int J Antimicrob Agents. 2010, 36: 459-461. 10.1016\/j.ijantimicag.2010.07.011","journal-title":"Int J Antimicrob Agents"},{"issue":"Suppl 3","key":"247_CR28","first-page":"15","volume":"62","author":"RA Seaton","year":"2008","unstructured":"Seaton RA: Daptomycin: rationale and role in the management of skin and soft tissue infections. J Antimicrob Chemother. 2008, 62 (Suppl 3): 15-23.","journal-title":"J Antimicrob Chemother"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-0711-11-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:47:00Z","timestamp":1630522020000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/1476-0711-11-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1186\/1476-0711-11-6","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"5 January 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"6"}}